Literature DB >> 24478917

Invasive meningococcal disease in elderly people, New South Wales, Australia, 1993 to 2012.

Praveena Gunaratnam1, Peter Massey2, David Durrheim3, Siranda Torvaldsen4.   

Abstract

Little information is available publicly on invasive meningococcal disease (IMD) in elderly people in Australia. This study analysed IMD notifications data from New South Wales between 1993 and 2012 to determine the distribution of IMD among people aged 65 years and older and to describe the characteristics of IMD in this age group compared to younger age groups with respect to notification trends, serogroup distribution and mortality rates. Following introduction of a childhood vaccination programme against meningococcal type C in 2003, notification rates in all age groups decreased, but the proportion of IMD notifications in people aged 65 years and over rose significantly (from 4% to 6%, P = 0.01). Mortality rates from IMD in those aged 65 years and older were significantly higher than overall rates (32% compared to 5%, P < 0.01). Serogroup Y accounted for 23% of infections in the elderly compared to 3% in people aged under 65 years (P < 0.01). As the population ages, the elderly may account for a higher number of IMD cases in Australia. Protocols at the state and national level should be updated to provide guidance on the clinical and public health management of elderly people with IMD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24478917      PMCID: PMC3902734          DOI: 10.5365/WPSAR.2013.4.4.001

Source DB:  PubMed          Journal:  Western Pac Surveill Response J        ISSN: 2094-7321


  10 in total

1.  Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002.

Authors:  Richard Brooks; Christopher W Woods; Daniel K Benjamin; Nancy E Rosenstein
Journal:  Clin Infect Dis       Date:  2006-05-24       Impact factor: 9.079

2.  Outbreaks of group B meningococcal disease--Florida, 1995 and 1997.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1998-10-09       Impact factor: 17.586

3.  Which contacts of patients with meningococcal disease carry the pathogenic strain of Neisseria meningitidis? A population based study.

Authors:  B E Kristiansen; Y Tveten; A Jenkins
Journal:  BMJ       Date:  1998-09-05

4.  Australia's notifiable disease status, 2010: annual report of the National Notifiable Diseases Surveillance System.

Authors:  Alison Milton; Stefan Stirzaker; Mark Trungove; Dougald Knuckey; Nicolee Martin; Chris Hastie; Kate Pennington; Timothy Sloan-Gardner; Gerard Fitzsimmons; Katrina Knope; Samantha Martinek; Lucas Mills; Christina Barry; Phil Wright; Mark Power
Journal:  Commun Dis Intell Q Rep       Date:  2012-03-31

5.  Carriage of Neisseria meningitidis in residents and staff at a residential home for elderly people following a case of invasive disease.

Authors:  D J Irwin; J G Crawshaw; R A Readman; L Teare; E B Kaczmarski
Journal:  Commun Dis Public Health       Date:  2000-09

Review 6.  The changing and dynamic epidemiology of meningococcal disease.

Authors:  Scott A Halperin; Julie A Bettinger; Brian Greenwood; Lee H Harrison; Jane Jelfs; Shamez N Ladhani; Peter McIntyre; Mary E Ramsay; Marco A P Sáfadi
Journal:  Vaccine       Date:  2011-12-15       Impact factor: 3.641

7.  Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease.

Authors:  Amanda C Cohn; Jessica R MacNeil; Lee H Harrison; Cynthia Hatcher; Jordan Theodore; Mark Schmidt; Tracy Pondo; Kathryn E Arnold; Joan Baumbach; Nancy Bennett; Allen S Craig; Monica Farley; Ken Gershman; Susan Petit; Ruth Lynfield; Arthur Reingold; William Schaffner; Kathleen A Shutt; Elizabeth R Zell; Leonard W Mayer; Thomas Clark; David Stephens; Nancy E Messonnier
Journal:  Clin Infect Dis       Date:  2010-01-15       Impact factor: 9.079

8.  Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Amanda C Cohn; Jessica R MacNeil; Thomas A Clark; Ismael R Ortega-Sanchez; Elizabeth Z Briere; H Cody Meissner; Carol J Baker; Nancy E Messonnier
Journal:  MMWR Recomm Rep       Date:  2013-03-22

9.  Annual report of the Australian Meningococcal Surveillance Programme, 2011.

Authors:  Monica M Lahra; Rodney P Enriquez
Journal:  Commun Dis Intell Q Rep       Date:  2012-09-30

10.  Invasive meningococcal capsular group Y disease, England and Wales, 2007-2009.

Authors:  Shamez N Ladhani; Jay Lucidarme; Lynne S Newbold; Stephen J Gray; Anthony D Carr; Jamie Findlow; Mary E Ramsay; Edward B Kaczmarski; Raymond Borrow
Journal:  Emerg Infect Dis       Date:  2012-01       Impact factor: 6.883

  10 in total
  8 in total

1.  New South Wales annual vaccine-preventable disease report, 2013.

Authors:  Alexander Rosewell; Paula Spokes; Robin Gilmour
Journal:  Western Pac Surveill Response J       Date:  2015-04-22

2.  Differences in the population structure of Neisseria meningitidis in two Australian states: Victoria and Western Australia.

Authors:  Shakeel Mowlaboccus; Christopher A Mullally; Peter C Richmond; Benjamin P Howden; Kerrie Stevens; David J Speers; Anthony D Keil; Ottar N Bjørnstad; Timothy T Perkins; Charlene M Kahler
Journal:  PLoS One       Date:  2017-10-24       Impact factor: 3.240

3.  Multidisciplinary analysis of invasive meningococcal disease as a framework for continuous quality and safety improvement in regional Australia.

Authors:  Kathryn A Taylor; David N Durrheim; Tony Merritt; Peter Massey; John Ferguson; Nick Ryan; Carolyn Hullick
Journal:  BMJ Open Qual       Date:  2018-02-07

4.  Epidemiology of two decades of invasive meningococcal disease in the Republic of Ireland: an analysis of national surveillance data on laboratory-confirmed cases from 1996 to 2016.

Authors:  D Bennett; P O'Lorcain; S Morgan; S Cotter; M Cafferkey; R Cunney
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

Review 5.  Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature.

Authors:  Sandra Guedes; Isabelle Bertrand-Gerentes; Keith Evans; Florence Coste; Philipp Oster
Journal:  BMC Public Health       Date:  2022-02-23       Impact factor: 3.295

6.  Epidemiology of invasive meningococcal disease and sequelae in the United Kingdom during the period 2008 to 2017 - a secondary database analysis.

Authors:  Sandra Guedes; Hélène Bricout; Edith Langevin; Sabine Tong; Isabelle Bertrand-Gerentes
Journal:  BMC Public Health       Date:  2022-03-17       Impact factor: 3.295

7.  Health Technology Assessment for Vaccines Against Rare, Severe Infections: Properly Accounting for Serogroup B Meningococcal Vaccination's Full Social and Economic Benefits.

Authors:  Andrew Stawasz; Liping Huang; Paige Kirby; David Bloom
Journal:  Front Public Health       Date:  2020-07-10

8.  Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adults 56 years of age and older: a Phase II randomized study.

Authors:  Judith Kirstein; Miriam Pina; Judy Pan; Emilia Jordanov; Mandeep S Dhingra
Journal:  Hum Vaccin Immunother       Date:  2020-04-01       Impact factor: 3.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.